ValuEngine downgraded shares of Nu Skin Enterprises (NYSE:NUS) from a buy rating to a hold rating in a report published on Friday morning.
Other equities analysts also recently issued reports about the company. Zacks Investment Research downgraded Nu Skin Enterprises from a hold rating to a sell rating in a report on Tuesday, January 8th. Jefferies Financial Group restated a buy rating and set a $92.00 price target on shares of Nu Skin Enterprises in a report on Thursday, November 8th. Tigress Financial restated a buy rating on shares of Nu Skin Enterprises in a report on Wednesday, November 21st. Citigroup set a $88.00 price target on Nu Skin Enterprises and gave the company a buy rating in a report on Thursday, November 8th. Finally, Bank of America restated an underperform rating and set a $65.00 price target (down from $75.00) on shares of Nu Skin Enterprises in a report on Thursday, December 6th. Two analysts have rated the stock with a sell rating, three have issued a hold rating and five have issued a buy rating to the company’s stock. Nu Skin Enterprises presently has a consensus rating of Hold and a consensus target price of $83.63.
Shares of NYSE:NUS opened at $67.06 on Friday. Nu Skin Enterprises has a 1-year low of $56.09 and a 1-year high of $88.68. The company has a quick ratio of 1.25, a current ratio of 1.93 and a debt-to-equity ratio of 0.44. The firm has a market cap of $3.73 billion, a PE ratio of 20.76, a P/E/G ratio of 1.53 and a beta of 0.69.
In related news, General Counsel D Matthew Dorny sold 2,500 shares of Nu Skin Enterprises stock in a transaction dated Monday, December 3rd. The stock was sold at an average price of $67.53, for a total value of $168,825.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 3.00% of the stock is currently owned by company insiders.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in NUS. Harvest Fund Management Co. Ltd increased its holdings in Nu Skin Enterprises by 162.9% in the 3rd quarter. Harvest Fund Management Co. Ltd now owns 1,291 shares of the company’s stock worth $106,000 after buying an additional 800 shares in the last quarter. First Hawaiian Bank bought a new stake in Nu Skin Enterprises in the 3rd quarter worth about $165,000. Advisors Asset Management Inc. increased its holdings in Nu Skin Enterprises by 16.0% in the 4th quarter. Advisors Asset Management Inc. now owns 2,720 shares of the company’s stock worth $167,000 after buying an additional 375 shares in the last quarter. Ffcm LLC increased its holdings in Nu Skin Enterprises by 181.9% in the 3rd quarter. Ffcm LLC now owns 1,911 shares of the company’s stock worth $177,000 after buying an additional 1,233 shares in the last quarter. Finally, Ibex Investors LLC purchased a new position in Nu Skin Enterprises in the third quarter worth about $201,000. Institutional investors own 74.53% of the company’s stock.
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems and targeted treatment products, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic, personal care, and hair care products.
Read More: What is a Market Correction?
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.